Zubsolv buprenorphine/naloxone regulatory update

Orexo and Mundipharma submitted an MAA to EMA for Zubsolv buprenorphine/naloxone to treat opioid dependence. The sublingual tablet of buprenorphine and naloxone is marketed in the U.S. for maintenance...